The buzz around novel obesity treatments including Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, shows no sign of quietening down in 2024. Obesity was the most talked about therapy area at the recent 2024 J.P. Morgan Healthcare Conference, with recent M&A activity and a heapin...